Uttiya Deb

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Lalit Kumar, Sameer Melinkeri, Prasanth Ganesan, Jeevan Kumar, Ghanashyam Biswas, Nalini Kilara, Harish Pathalingappa, Svss Prasad, Minish Jain, Sourav Kumar Mishra, Saurabh Prasad, Pavan Kumar Boyella, Ranjit Kumar Sahoo, Shailesh Bondarde, Sandip Shah, Milind Rege, Uttiya Deb, Tanuja Korde, Jitendra Dixit
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study. Future oncology (London, England) 20 (4) (2023)
Lalit Kumar, Sameer Melinkeri, Prasanth Ganesan, Jeevan Kumar, Ghanashyam Biswas, Nalini Kilara, Harish Pathalingappa, Svss Prasad, Minish Jain, Sourav Kumar Mishra, Saurabh Prasad, Pavan Kumar Boyella, Ranjit Kumar Sahoo, Shailesh Bondarde, Sandip Shah, Milind Rege, Uttiya Deb, Tanuja Korde, Jitendra Dixit
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study. Future oncology (London, England) 20 (4) (2023)
Lalit Kumar, Sameer Melinkeri, Prasanth Ganesan, Jeevan Kumar, Ghanashyam Biswas, Nalini Kilara, Harish Pathalingappa, Svss Prasad, Minish Jain, Sourav Kumar Mishra, Saurabh Prasad, Pavan Kumar Boyella, Ranjit Kumar Sahoo, Shailesh Bondarde, Sandip Shah, Milind Rege, Uttiya Deb, Tanuja Korde, Jitendra Dixit
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study. Future oncology (London, England) 20 (4) (2023)
Lalit Kumar, Sameer Melinkeri, Prasanth Ganesan, Jeevan Kumar, Ghanashyam Biswas, Nalini Kilara, Harish Pathalingappa, Svss Prasad, Minish Jain, Sourav Kumar Mishra, Saurabh Prasad, Pavan Kumar Boyella, Ranjit Kumar Sahoo, Shailesh Bondarde, Sandip Shah, Milind Rege, Uttiya Deb, Tanuja Korde, Jitendra Dixit
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study. Future oncology (London, England) (2023)
Uttiya Deb, Sandip Mukhopadhyay, Biswamit Bhattacharya, Sanatan Banerjee, Supreeti Biswas
Efficacy and safety of modafinil versus dexamethasone in cancer-related fatigue: a prospective randomized controlled study. Future oncology (London, England) 17 (14) (2021)

Uttiya Deb.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Uttiya Deb